StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.55−0.30 (-6.19%)

Close on Nov 16, 2026Market cap $36.69MP/E –Yield –

Cryo-Cell International operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cryo-Cell International's operating income for the twelve months ending Aug 31, 2026 was $189.42K, down 95.6% year over year. For fiscal 2025 it was $482.39K, down 86.1% from the year before. Over ten years it grew -16.5% a year on average. The highest annual figure on record is $7.66M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Nov 30, 2025$482.39K-86.1%
FY2024Nov 30, 2024$3.48M–
FY2023Nov 30, 2023-$12.30M-405.7%
FY2022Nov 30, 2022$4.02M+0.2%
FY2021Nov 30, 2021$4.02M-47.6%
FY2020Nov 30, 2020$7.66M+51.3%
FY2019Nov 30, 2019$5.06M-2.4%
FY2018Nov 30, 2018$5.19M+3.7%
FY2017Nov 30, 2017$5.01M+1054.6%
FY2016Nov 30, 2016$433.59K-85.2%
FY2015Nov 30, 2015$2.93M+48.1%
FY2014Nov 30, 2014$1.98M+16.4%
FY2013Nov 30, 2013$1.70M–
FY2012Nov 30, 2012-$1.71M–
FY2011Nov 30, 2011-$276.74K-108.3%
FY2010Nov 30, 2010$3.35M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$2.19M+15.4%
Q2 FY2026CQ2 2026May 31, 2026$1.20M-19.8%
Q1 FY2026CQ1 2026Feb 28, 2026$765.13K-27.5%
Q4 FY2025CQ4 2025Nov 30, 2025-$3.97M–
Q3 FY2025CQ3 2025Aug 31, 2025$1.90M+36.7%
Q2 FY2025CQ2 2025May 31, 2025$1.49M+7.3%
Q1 FY2025CQ1 2025Feb 28, 2025$1.06M+28.6%
Q4 FY2024CQ4 2024Nov 30, 2024-$122.35K–
Q3 FY2024CQ3 2024Aug 31, 2024$1.39M+19.7%
Q2 FY2024CQ2 2024May 31, 2024$1.39M+35.4%
Q1 FY2024CQ1 2024Feb 29, 2024$821.22K-51.2%
Q4 FY2023CQ4 2023Nov 30, 2023-$16.18M-4090.6%
Q3 FY2023CQ3 2023Aug 31, 2023$1.16M+21.7%
Q2 FY2023CQ2 2023May 31, 2023$1.03M-13.9%
Q1 FY2023CQ1 2023Feb 28, 2023$1.68M+14.5%
Q4 FY2022CQ4 2022Nov 30, 2022$405.36K–
Q3 FY2022CQ3 2022Aug 31, 2022$954.31K-40.2%
Q2 FY2022CQ2 2022May 31, 2022$1.19M-40.1%
Q1 FY2022CQ1 2022Feb 28, 2022$1.47M+19.0%
Q4 FY2021CQ4 2021Nov 30, 2021-$808.43K-137.1%
Q3 FY2021CQ3 2021Aug 31, 2021$1.60M-35.6%
Q2 FY2021CQ2 2021May 31, 2021$2.00M+13.9%
Q1 FY2021CQ1 2021Feb 28, 2021$1.24M-1.1%
Q4 FY2020CQ4 2020Nov 30, 2020$2.18M+26.8%
Q3 FY2020CQ3 2020Aug 31, 2020$2.48M+24.4%
Q2 FY2020CQ2 2020May 31, 2020$1.75M+252.9%
Q1 FY2020CQ1 2020Feb 29, 2020$1.25M+46.3%
Q4 FY2019CQ4 2019Nov 30, 2019$1.72M-19.4%
Q3 FY2019CQ3 2019Aug 31, 2019$1.99M+116.6%
Q2 FY2019CQ2 2019May 31, 2019$496.56K-56.8%
Q1 FY2019CQ1 2019Feb 28, 2019$853.66K-13.5%
Q4 FY2018CQ4 2018Nov 30, 2018$2.13M+71.2%
Q3 FY2018CQ3 2018Aug 31, 2018$920.12K-36.6%
Q2 FY2018CQ2 2018May 31, 2018$1.15M-3.6%
Q1 FY2018CQ1 2018Feb 28, 2018$987.14K-11.6%
Q4 FY2017CQ4 2017Nov 30, 2017$1.25M+172.6%
Q3 FY2017CQ3 2017Aug 31, 2017$1.45M–
Q2 FY2017CQ2 2017May 31, 2017$1.19M–
Q1 FY2017CQ1 2017Feb 28, 2017$1.12M–
Q4 FY2016CQ4 2016Nov 30, 2016$456.86K–

More Cryo-Cell International figures

See a number that looks wrong?